In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells. (Q39671865)
Jump to navigation
Jump to search
scientific article published on 3 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells. |
scientific article published on 3 August 2010 |
Statements
In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells (English)
Virginia Seiffart
Jessy Presumey
Virginie Escriou
Daniel Scherman
Jochen Zwerina
Gisela Ruiz
Siegfried Weiss
Andrea Hoffmann
Gerhard Gross
3 August 2010